Orthostatic hypercoagulability - A novel physiological mechanism to activate the coagulation system

被引:49
作者
Masoud, Muhannad
Sarig, Galit
Brenner, Benjamin
Jacob, Giris [1 ]
机构
[1] Rambam Med Ctr, J Recanati Auton Dysfunct Ctr, IL-31096 Haifa, Israel
关键词
prolonged standing; coagulation; protein C global; endothelial activity;
D O I
10.1161/HYPERTENSIONAHA.108.112003
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Orthostatic stress causes significant plasma shift and raises transmural pressure in lower extremities, resulting in an increase in endothelial activation and plasma proteins concentrations, possibly including coagulation factors. This may lead to activation of the coagulation system during standing. To test this hypothesis, we recruited 18 healthy volunteers (9 females and 9 males; mean age: 25 +/- 1.2 years; body mass index: 21.7 +/- 0.5 kg/m(2)). Hemodynamics, plasma shift (extrapolated from sequential hematocrit concentration), plasma proteins, and coagulation tests, including procoagulants; fibrinogen, factor V, and factor VIII activity; prothrombin fragments 1 and 2; and endothelial activation-related factors (tissue factor and von Willebrand factor), as well as protein C global pathway, were determined at rest supine and at 15 minutes, 30 minutes, and 60 minutes of still standing. Thirty minutes of standing caused a decrease in plasma volume by 12.0 +/- 0.5% and an increase in plasma protein by 13.0 +/- 0.7%. Fibrinogen, factor V, and factor VIII activity rose by 12.0 +/- 1.2%, 13.0 +/- 1.0%, and 40.0 +/- 6.0% (P < 0.002 for all), respectively. Prothrombin fragments 1 and 2 were elevated by 150.0 +/- 30.0%. Tissue factor and von Willebrand factor increased by 30.0 +/- 9.0% and 17.4 +/- 51.0% (P < 0.02 for both), respectively. However, protein C assay results decreased from 0.95 +/- 0.20 to 0.83 +/- 0.16 (P < 0.001). We hereby introduce a novel physiological mechanism, "orthostatic procoagulation," that should be considered during coagulation tests. Furthermore, it could be extrapolated to the pathophysiology of stasis and venous thromboembolism.
引用
收藏
页码:1545 / 1551
页数:7
相关论文
共 42 条
[1]  
Anderson AF, 2003, CIRCULATION S1, V107, P9, DOI [10.1161/01.CIR.0000078469.07362.E6, DOI 10.1161/01.CIR.0000078469.07362.E6]
[2]   Endothelial function in different organs [J].
Bassenge, E .
PROGRESS IN CARDIOVASCULAR DISEASES, 1996, 39 (03) :209-228
[3]   Thrombophilia and pregnancy complications [J].
Brenner, Benjamin .
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2006, 35 (1-2) :28-35
[4]   Management of thromboembolism in hematologic malignancies [J].
Chong, Beng H. ;
Lee, Szu-Hee .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2007, 33 (04) :435-447
[5]   Virchow's triad revisited: Blood constituents [J].
Chung, I ;
Lip, GYH .
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 (5-6) :449-454
[6]  
Dati F, 1997, CLIN CHEM, V43, P1719
[7]   The prothrombotic paradox of hypertension - Role of the renin-angiotensin and kallikrein-kinin systems [J].
Dielis, AWJH ;
Smid, M ;
Spronk, HMH ;
Hamulyak, K ;
Kroon, AA ;
ten Cate, H ;
de Leeuw, PW .
HYPERTENSION, 2005, 46 (06) :1236-1242
[8]  
Dormandy J A, 1970, Ann R Coll Surg Engl, V47, P211
[9]   Risk of venous thromboembolism among hospitalized medically ill patients [J].
Edelsberg, John ;
Hagiwara, May ;
Taneja, Charu ;
Oster, Gerry .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 :S16-S22
[10]   Endothelial function and its assessment [J].
Felmeden, DC ;
Lip, GYH .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (11) :1319-1336